Search results for "Gastroesophageal reflux disease"

showing 10 items of 14 documents

Protective and regenerative effects of a novel medical device against esophageal mucosal damage using in vitro and ex vivo models.

2020

Gastroesophageal reflux disease (GERD) is a common digestive disorder that causes esophagitis and injuries to the esophageal mucosa. GERD symptoms are recurrent during pregnancy and their treatment is focused on lifestyle changes and nonprescription medicines. The aim of this study was to characterize the mechanism of action of a new patented medical device, an oral formulation containing hyaluronic acid, rice extract, and amino acids dispersed in a bioadhesive polymer matrix, by assessing its protective effects in in vitro and ex vivo models of esophageal mucosa damage. Acidic bile salts and pepsin cocktail (BSC) added to CP-A and COLO-680 N esophagus cells were used as an in vitro GERD mo…

0301 basic medicineEsophageal MucosaHyaluronic acidRM1-950PharmacologyPermeability03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePepsinCell Line TumorDigestive disorderHyaluronic acidMedicineHumansRegenerationEsophagusAmino AcidsHyaluronic AcidEvans BlueMedical devicePharmacologybiologybusiness.industryBioadhesive polymer; Gastroesophageal reflux disease (GERD); Hyaluronic acid; Medical device; Rice extractPlant ExtractsRice extractAdhesivenessOryzaGeneral MedicineBioadhesive polymermedicine.diseaseGastroesophageal reflux disease (GERD)digestive system diseases030104 developmental biologymedicine.anatomical_structurechemistryEquipment and Supplies030220 oncology & carcinogenesisbiology.proteinGERDGastroesophageal RefluxTherapeutics. PharmacologybusinessWound healingEx vivoBiomedicinepharmacotherapy = Biomedecinepharmacotherapie
researchProduct

Do patients with gastroesophageal reflux disease and somatoform tendencies benefit from antireflux surgery?

2019

Source at http://dx.doi.org/10.3748/wjg.v25.i3.388. BACKGROUND - The clinical presentation of gastroesophageal reflux disease (GERD) shows a large symptom variation also in different intensities among patients. As several studies have shown, there is a large overlap in the symptomatic spectrum between proven GERD and other disorders such as dyspepsia, functional heartburn and/or somatoform disorders. AIM - To prospectively evaluate the GERD patients with and without somatoform disorders before and after laparoscopic antireflux surgery. METHODS - In a tertiary referral center for foregut surgery over a period of 3 years patients with GERD, qualifying for the indication of laparoscopic antire…

AdultMalemedicine.medical_specialtyPsychometricsFundoplicationDiseaseLaparoscopic fundoplicationGastroesophageal reflux disease03 medical and health sciencesYoung Adult0302 clinical medicineQuality of lifeInternal medicineVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Gastroscopic surgery: 781medicineHumansddc:610Prospective StudiesYoung adultAntireflux surgeryLaparoscopyProspective cohort studySomatoform DisordersVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Gasteroenterologisk kirurgi: 781AgedAged 80 and overmedicine.diagnostic_testbusiness.industryGastroenterologyRefluxGeneral MedicineMiddle Agedmedicine.diseasehumanitiesdigestive system diseasesTreatment OutcomeSomatization030220 oncology & carcinogenesisGERDGastroesophageal RefluxQuality of LifeProspective Study030211 gastroenterology & hepatologyFemaleLaparoscopybusinessSomatizationGastroesophageal reflux disease symptomsWorld Journal of Gastroenterology
researchProduct

Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis: No Data for Supporting a Relationship After a Systematic Review

2019

Gastroesophageal Reflux Disease
researchProduct

ORAL MANIFESTATIONS IN GASTROESOPHAGEAL REFLUX DISEASE

2005

The gastroesophageal reflux (passage of gastric contents into the oesophagus and the mouth) is the main sign/symptom of a very frequent gastroesophageal reflux disease. Thus, acid regurgitation originates from stomach and it is responsible of the onset of tipical symptoms and mucosal injury. Also in oral cavity the noxious acid agent is able to injure oral cavity (soft and hard tissues). These involvementes are described from international literature, even if a greater interest has shown to date only for hard tissue injury.

Gastroesophageal reflux disease oral manifestations
researchProduct

Gastritis and gastroesophageal reflux disease are strongly associated with non-allergic nasal disorders

2021

AbstractBackgroundGastroesophageal reflux disease (GERD) has been reported to be significantly associated with chronic rhinosinusitis, but the strength of the association is still debated.AimsTo evaluate the strength of the association between gastritis/GERD and non-allergic rhinitis (NAR)/allergic rhinitis (AR)/sinusitis.MethodsWe investigated 2887 subjects aged 20–84 years, who underwent a clinical visit in seven Italian centres (Ancona, Palermo, Pavia, Terni, Sassari, Torino, Verona) within the study on Gene Environment Interactions in Respiratory Diseases, a population-based multicase-control study between 2008 and 2014. Subjects were asked if they had doctor-diagnosed “gastritis or sto…

MaleNon-allergic rhinitisGastroesophageal reflux diseaseGastroenterologyAllergic rhinitis0302 clinical medicinePrevalenceNon-allergic rhiniti030223 otorhinolaryngologySinusitisRhinitisAged 80 and overeducation.field_of_studyMiddle AgedGastrititItalyGastritisGastroesophageal RefluxFemalePublic HealthGastritismedicine.symptomResearch ArticleAdultPulmonary and Respiratory Medicinemedicine.medical_specialtyPopulationGastrititsSettore MED/10 - Malattie Dell'Apparato RespiratorioNOHiatal herniaGastritits Gastroesophageal refux disease Allergic rhinitis Non-allergic rhinitis SinusitisYoung Adult03 medical and health sciencesAllergic rhinitis; Gastritits; Gastroesophageal reflux disease; Non-allergic rhinitis; SinusitisInternal medicineAllergic rhinitimedicineHumansGastroesophageal refux diseaseSinusitiseducationAgedlcsh:RC705-779business.industrylcsh:Diseases of the respiratory systemmedicine.diseaseRhinitis AllergicSinusitidigestive system diseases030228 respiratory systemRelative riskChronic DiseaseGERDAllergic rhinitis; Gastritits; Gastroesophageal reflux disease; Non-allergic rhinitis; Sinusitis Public HealthNon-allergic rhinitisbusinessEsophagitis
researchProduct

Evaluation of esophageal motility and reflux in children treated for esophageal atresia with the use of combined multichannel intraluminal impedance …

2011

Abstract Background Gastroesophageal reflux (GER) and dysmotility are frequent in patients treated for esophageal atresia (EA). This aim of this study is to evaluate GER and dysmotility in young EA patients using pH–multichannel intraluminal impedance (pH-MII). Methods Fifteen patients with a mean age of 7.5 years (group 1) have been studied and compared with 15 children without congenital malformation, submitted to pH-MII for suspected GER (group 2). These latter patients serve as a control group of healthy subjects. The following impedance reflux and motility parameters have been studied on 10 standardized swallows: number of reflux episodes, mean acid clearing time, median bolus clearing…

Malemedicine.medical_specialtyEsophageal pH MonitoringMonitoring AmbulatoryTransit timeGastroesophageal reflux diseasePh monitoringGastroenterologyBolus (medicine)EsophagusPostoperative ComplicationsInternal medicinemedicineElectric ImpedanceEsophagitisHumansIn patientEsophageal Motility DisordersChildEsophageal Atresiabusiness.industrySettore MED/20 - Chirurgia Pediatrica E InfantileRefluxHealthy subjectsGeneral Medicinemedicine.diseaseEsophageal dysmotilityMultichannel Intraluminal ImpedanceDeglutitionEsophageal pHAtresiaChild PreschoolPediatrics Perinatology and Child HealthGastroesophageal RefluxSurgeryFemalePeristalsisEsophagoscopybusinessRheologyEsophageal motilityTracheoesophageal FistulaJournal of pediatric surgery
researchProduct

Gastroesophageal reflux in patients treated for congenital diaphragmatic hernia: short- and long-term evaluation with multichannel intraluminal imped…

2013

The incidence of GER, related symptoms and complications in patients treated for congenital diaphragmatic hernia (CDH) are poorly defined. The aim was to evaluate incidence and development of GER in children treated for CDH in a short- and long-term follow-up period, identifying potential risk factors of morbidity. Thirty-six patients were evaluated with pH-MII at a median age of 6 months (T1) and re-evaluated with pH-MII and endoscopy at a median age of 5 years (T2). The incidence of reflux was 83 % in T1 and 61 % in T2; the incidence of symptoms was 62 % in T1 and 38 % in T2. In both groups the reflux was mainly non-acidic. Patch, intrathoracic stomach and esophageal dysmotility were risk…

Malemedicine.medical_specialtyTime FactorsCongenital diaphragmatic hernia Gastroesophageal reflux disease Esophageal dysmotility Multichannel intraluminal impedance Endoscopic esophagitisDiaphragmatic breathingAsymptomaticGastroenterologyEsophagusInternal medicinemedicineElectric ImpedanceHumansHerniaRisk factorHerniorrhaphyRetrospective StudiesHernia Diaphragmaticbusiness.industryIncidence (epidemiology)IncidenceSettore MED/20 - Chirurgia Pediatrica E InfantileRefluxCongenital diaphragmatic herniaInfantGeneral MedicineHydrogen-Ion Concentrationmedicine.diseaseSurgeryItalyPediatrics Perinatology and Child HealthGastroesophageal RefluxSurgeryFemaleEsophagoscopymedicine.symptombusinessHernias Diaphragmatic CongenitalEsophagitisFollow-Up StudiesPediatric surgery international
researchProduct

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life

2021

Abstract Background and aims Severe asthma is burdened by frequent exacerbations and use of oral corticosteroids (OCS) which worsen patients’ health and increase healthcare spending. Aim of this study was to assess the clinical and economic effect of adding mepolizumab (MEP) for the treatment of these patients. Methods Patients >18 years old, referred to 8 asthma clinics, starting MEP between May 2017 and December 2018, were enrolled and followed-up for 12 months. Information in the 12 months before mepolizumab were collected retrospectively. The evaluation parameters included: OCS use, number of exacerbations/hospitalizations, concomitant therapies, comorbidity, and annual number of workin…

OR Odds RatioPediatricsSevere asthmaExacerbationAnti IL-5; Comorbidities; Mepolizumab; OCS; Pharmacoeconomics; Severe asthmagastroesophageal reflux diseaseSettore MED/10 - MALATTIE DELL'APPARATO RESPIRATORIOICS inhaled corticosteroidRate ratioOCS Oral Corticosteroidslaw.inventionComorbiditiesLAMA long acting muscarinic antagonist0302 clinical medicineRandomized controlled trialfractional nitric oxideInterquartile rangelawlong acting beta 2 agonistOdds RatioImmunology and AllergyRR Rate Ratio030223 otorhinolaryngologyPharmacoeconomicLOS Length of stayLOSIQRLAMAMEP MepolizumabORCISD Standard DeviationMEPPharmacoeconomicsACT Asthma Control TestComorbiditieCI Confidence Intervalsmedicine.druglcsh:Immunologic diseases. AllergyPulmonary and Respiratory Medicinemedicine.medical_specialtyinterquartile rangelong acting muscarinic antagonistImmunologyLABALABA long acting beta 2 agonistComorbidities Mepolizumab OCS Pharmacoeconomics Severe asthma Anti IL-5RRArticleRate Ratiochronic obstructive pulmonary disease03 medical and health sciencesPharmacoeconomicsOCS Oral CorticosteroidAsthma Control TestConfidence IntervalsFeNO fractional nitric oxideRCTs Randomized Controlled TrialmedicineCOPDGERD gastroesophageal reflux diseaseFeNOIQR interquartile rangeMepolizumabSDAsthmaRCTsOral Corticosteroidsbusiness.industryGERDmedicine.diseaseICS inhaled corticosteroidsACTComorbidityRandomized Controlled TrialsCI Confidence IntervalRCTs Randomized Controlled TrialsOCSCOPD chronic obstructive pulmonary disease030228 respiratory systemICSStandard DeviationLength of stayAnti IL-5inhaled corticosteroidslcsh:RC581-607businessMepolizumab
researchProduct

Columnar-Lined Esophagus CK7 Positive is an Early Marker of Gastroesophageal Reflux Disease

2011

LETTER TO EDITOR

Pathologymedicine.medical_specialtybusiness.industryRefluxColumnar-lined esophagusSettore MED/08 - Anatomia PatologicaPathology and Forensic Medicinemedicine.anatomical_structureKeratin 7MedicineSurgeryGastroesophageal Reflux Disease Barrett EsophagusAnatomyEsophagusbusiness
researchProduct

Relationship between Helicobacter pylori infection and GERD

2018

Gastroesophageal reflux disease (GERD) is due to the chronic exposure of the esophageal mucosa to acid secretion from the stomach. Helicobacter pylori (H.p.) infection, is a risk factor for the development of peptic ulcer, atrophic gastritis and gastric cancer, and causes various effects on gastric function. The relationship between GERD and H.pylori infection is still subject of debate.Background and aim: In literature no clear causal relationship has been established between GERD and H. pylori infection, although some papers support the onset of esophagitis in patients in whom the infection has been cured. Aim of this work is to review the most recent literature data about the relationshi…

Peptic UlceresophagitisHelicobacter pylorigastroesophageal reflux diseaseSmokingReviewGERDhumanitiesdigestive system diseasesAnti-Bacterial AgentsHelicobacter InfectionsCausalityacid-related disordersStomach NeoplasmsGastritisGastroesophageal RefluxHumansEsophagitis PepticActa bio-medica : Atenei Parmensis
researchProduct